Areas of Focus
- Research on the mechanisms of hepatobiliary tumor development
Work Experience
- 2014.07-2016.09 - Harbin Medical University First Affiliated Hospital - Assistant Researcher, Physician
- 2014.12-2015.12 - Rutgers University New Jersey Cancer Institute - Visiting Scholar
- 2016.10-2018.10 - Harbin Medical University First Affiliated Hospital - Associate Researcher, Attending Physician
- 2018.11-present - University of Science and Technology of China First Affiliated Hospital - Associate Researcher, Associate Chief Physician
Academic Background & Achievements
- 2003.09-2008.07 Bachelor: Xinxiang Medical University
- 2008.09-2011.07 Master: Harbin Medical University
- 2011.09-2014.07 Doctorate: Harbin Medical University
Publications
- MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways., Tiemin P, Fanzheng M, Peng X, Jihua H, Ruipeng S, Yaliang L, Yan W, Junlin X, Qingfu L, Zhefeng H, Jian L, Zihao G, Guoxing L, Boshi S, Ming Z, Qinghui M, Desen L, Lianxin L., 2020
- NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways., Meng F, Zhang S, Song R, Liu Y, Wang J, Liang Y, Wang J, Han J, Song X, Lu Z, Yang G, Pan S, Li X, Liu Y, Zhou F, Wang Y, Cui Y, Zhang B, Ma K, Zhang C, Sun Y, Xin M, Liu L., 2019
- γ-Tocotrienol-Inhibited Cell Proliferation of Human Gastric Cancer by Regulation of Nuclear Factor-κB Activity., Sun WG, Song RP, Wang Y, Zhang YH, Wang HX, Ge S, Liu JR, Liu LX., 2019
- Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation., Liu X, Liang Y, Song R, Yang G, Han J, Lan Y, Pan S, Zhu M, Liu Y, Wang Y, Meng F, Cui Y, Wang J, Zhang B, Song X, Lu Z, Zheng T, Liu L., 2018
Awards
- Natural Science (2017): First Prize by Ministry of Education, 7th place